nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abuse and Misuse of Pregabalin and Gabapentin
|
Evoy, Kirk E. |
|
2017 |
77 |
4 |
p. 403-426 |
artikel |
2 |
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
|
Keating, Gillian M. |
|
2017 |
77 |
4 |
p. 459-472 |
artikel |
3 |
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
|
Scott, Lesley J. |
|
2017 |
77 |
4 |
p. 435-445 |
artikel |
4 |
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
|
Scott, Lesley J. |
|
|
77 |
4 |
p. 435-445 |
artikel |
5 |
Daclizumab: A Review in Relapsing Multiple Sclerosis
|
Shirley, Matt |
|
|
77 |
4 |
p. 447-458 |
artikel |
6 |
Daclizumab: A Review in Relapsing Multiple Sclerosis
|
Shirley, Matt |
|
2017 |
77 |
4 |
p. 447-458 |
artikel |
7 |
Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview
|
Hindryckx, Pieter |
|
2017 |
77 |
4 |
p. 379 |
artikel |
8 |
Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview
|
Hindryckx, Pieter |
|
2017 |
77 |
4 |
p. 363-377 |
artikel |
9 |
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
|
Lener, Marc S. |
|
2017 |
77 |
4 |
p. 381-401 |
artikel |
10 |
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
|
Berry, Michael |
|
2017 |
77 |
4 |
p. 353-361 |
artikel |
11 |
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
|
Berry, Michael |
|
|
77 |
4 |
p. 353-361 |
artikel |
12 |
Nusinersen: First Global Approval
|
Hoy, Sheridan M. |
|
2017 |
77 |
4 |
p. 473-479 |
artikel |
13 |
Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence
|
Gagne, Joshua J. |
|
2017 |
77 |
4 |
p. 427-433 |
artikel |